SYMPOSIUM FORM
Presenting Author's information
First Name*
Last Name*
Institution Name*
Address*
Zip Code*
City*
Country*
Phone*
Date of birth*
Mail*
Confirm mail*
Short Curriculum Vitae
SELECT A FILE
.doc or .pdf - maximum 3 MB
0%
Symposium details
Title*
1. Heart failure: anything new on the horizon?
2. Targeting purinergic receptors to promote damage resolution and repair in neurodegenerative diseases
3. Early synaptic failure: from developmental to age related diseases
4. When the interaction leads to dysfunction: new perspectives for therapeutic intervention in Neurodegenerative Diseases
5. Tackling progression of Multiple Sclerosis: from pathogenesis of neurodegeneration to therapeutic opportunities
6. CNS disorders: much more than neurons
7. Epigenetic and genetic modulation in substance use disorders
8. Pharmacological effects and genotoxic properties of synthetic psychoactive substances
9. Substance use disorder across life: from neurobiological mechanisms to new pharmacological treatments
10. The role of Real-World Evidence in healthcare emergency for informed drug regulatory decision making
11. From medication review to deprescribing: new strategies to improve a rationale use of medicine
12. Neurobiology of Post-Traumatic Stress Disorder: from rodents to patients
13. Central and peripheral redox dysregulation and inflammation in neuropsychiatric disorders: from molecular targets to novel therapeutic opportunities
14. New insights in Autism Spectrum Disorders: from basic science to novel therapeutic approaches
15. Translational Pharmacology in Disease-induced depression: from genes to hard-data to therapy
16. Precision medicine and pharmacological treatment of psychiatric disorders
17. New targets for pain eradication
18. Strategies for the therapy of visceral hypersensitivity
19. Pain and Opioids: from preclinical news to clinical perspectives
20. New possible pharmacological targets for the treatment of eating disorders
21. New possible pharmacological targets for the treatment of obesity and metabolic syndrome
22. Nutraceuticals: clinical efficacy and safety
23. Frontiers in Immunomodulation
24. Gut microbiota-brain-immune axis: emerging evidence for a role in neurological conditions
25. Translational research openings for the cure of amyotrophic lateral sclerosis
26. The value of research in rare diseases in the pandemic era
27. New trends in hereditary rare channelopathies: complex genetics, phenotype heterogeneity and precision medicine
28. Novel drugs and therapies for rare genetic pediatric diseases (joint symposium GdL Farmacologia Pediatrica e GdL SIF4RARE)
29. Pharmacogenetics in perosnalised therapy: the impact of big data and artificial intelligence
30. State of the art and perspectives in cancer pharmacology (I)
31. State of the art and perspectives in cancer pharmacology (II)
32. Gender pharmacology and SARS-CoV-2: a call for action
33. Drugs in the environment: risk assessment, regulatory landscape and future challenges
34. (R)evolution of cancer therapy: are we ready to identify and manage the new safety features?
35. Advanced Therapies for Ocular Rare Diseases
36. Non-coding RNA based strategies in sporadic and familial neurodegenerative disorders
37. As time goes by: ageing and the heart
38. OTHER
Other*
Abstract body*
(maximum 3000 characters, including spaces)
I confirm that I have read the warning on
data processing and privacy policy
CONFERMA
